16 Guion Place, New Rochelle, NY, 10802 · (914) 632-5000
Beds
141
FY 2025
Star rating
1 of 5
Patient survey: 2 of 5
Net patient revenue
$176.4M
FY 2025
Net income
-$51.9M
Patient care margin -45.6%
Discharges
5,912
Occupancy 52.9%
Clinicians
227
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $176.4M | $256.8M | -45.6% | -$51.9M | 5,912 | $7.2M | 32.5% | 5.1% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for COPD patients | 8.3% | US median 8.5% |
| Death rate for heart attack patients | 13.3% | US median 11.8% |
| Death rate for heart failure patients | 10.5% | US median 11% |
| Hospital-wide death rate within 30 days | 3.4% | US median 3.9% |
| Death rate for pneumonia patients | 17.6% | US median 15.2% |
| Death rate for stroke patients | 11% | US median 11.6% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | - | $250.2M | - | - | 5,268 | $7.0M | 31.4% | 5.4% |
| 2023 | $162.7M | $234.4M | -44.1% | -$49.4M | 5,150 | $3.8M | 34.9% | 6.3% |
| 2022 | $159.6M | $226.5M | -41.9% | -$19.9M | 5,439 | $4.1M | 37.0% | 6.6% |
| 2021 | $150.1M | $214.7M | -43.0% | -$5.7M | 5,397 | $3.2M | 36.1% | 7.3% |
| 2020 | $143.3M | $214.6M | -49.8% | -$1.8M | 4,827 | $4.2M | 39.8% | 8.2% |
Revenue and income are left empty for fiscal year 2024: that cost report was filed without contractual allowances, so its net revenue would equal gross charges.
| Readmission rate for COPD | 20.4% | US median 19.8% |
| Readmission rate for heart failure | 23.5% | US median 21.3% |
| Readmission rate after hip or knee replacement | 4.7% | US median 5.8% |
| Readmission rate for pneumonia | 16.6% | US median 17.2% |
| Complications after hip or knee replacement | 2.6% | US median 4.1% |
| Serious complications (patient safety composite) | 0.94 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.33 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 1.31 | US median 0.48 |
| MRSA bloodstream infections (ratio to expected) | 0.85 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.47 | US median 0.40 |
| Doctors always communicated well | 76% | US median 79% |
| Nurses always communicated well | 74% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 55% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 58% | US median 72% |
| Room and bathroom always clean | 70% | US median 73% |
| Patients who would definitely recommend the hospital | 60% | US median 71% |
| Patients who left the emergency department before being seen | 1% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 178 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 19% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 57% | US median 65% |
| Healthcare workers given the flu vaccine | 69% | US median 79% |
| DRG 291 HEART FAILURE AND SHOCK WITH MCC | 65 | $71,918.05 | $12,404.72 | $10,022.34 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 40 | $106,927.10 | $15,089.75 | $9,867.73 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 36 | $63,679.92 | $9,021.33 | $7,681.44 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 33 | $44,723.76 | $7,390.18 | $5,985.69 |
| DRG 870 SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS | 31 | $251,531.26 | $65,505.87 | $58,777.93 |
| DRG 462 BILATERAL OR MULTIPLE MAJOR JOINT PROCEDURES OF LOWER EXTREMITY WITHOUT MCC | 31 | $130,786.84 | $25,285.87 | $22,967.97 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 30 | $79,816.77 | $15,969.93 | $12,667.88 |
| DRG 189 PULMONARY EDEMA AND RESPIRATORY FAILURE | 27 | $82,707.85 | $11,891.30 | $9,973.97 |
| DRG 689 KIDNEY AND URINARY TRACT INFECTIONS WITH MCC | 26 | $64,201.31 | $10,532.42 | $8,838.11 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 23 | $51,673.35 | $12,706.26 | $10,642.23 |
| DRG 682 RENAL FAILURE WITH MCC | 21 | $89,865.10 | $12,795.52 | $11,457.18 |
| DRG 378 GASTROINTESTINAL HEMORRHAGE WITH CC | 20 | $53,387.40 | $9,484.45 | $7,294.77 |
| DRG 178 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH CC | 18 | $67,031.39 | $9,234.44 | $7,278.86 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5115 Level 5 Musculoskeletal Procedures | 56 | 56 | $13,316.07 | $10,771.69 |
| APC 5112 Level 2 Musculoskeletal Procedures | 47 | 46 | $1,456.35 | $1,196.16 |
| APC 5113 Level 3 Musculoskeletal Procedures | 24 | 23 | $2,934.63 | $2,373.24 |
| APC 5341 Level 1 Abdominal/Peritoneal/Biliary and Related Procedures | 19 | 19 | $3,122.87 | $2,635.67 |
| APC 5114 Level 4 Musculoskeletal Procedures | 18 | 18 | $6,508.30 | $5,338.75 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 15 | 15 | $1,469.91 | $1,219.56 |
| APC 5375 Level 5 Urology and Related Services | 14 | 14 | $4,686.92 | $3,917.51 |
| APC 5183 Level 3 Vascular Procedures | 14 | 14 | $2,889.87 | $2,405.01 |
| APC 5374 Level 4 Urology and Related Services | 11 | 11 | $3,160.68 | $2,629.24 |
| APC 5414 Level 4 Gynecologic Procedures | - | - | - | $2,389.24 |
| APC 5431 Level 1 Nerve Procedures | - | - | - | $1,406.61 |
| APC 5462 Level 2 Neurostimulator and Related Procedures | - | - | - | $4,524.18 |
Reported payments to this teaching hospital
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Montefiore New Rochelle Hospital is a nonprofit short-term acute care hospital in New Rochelle, NY with 141 beds, part of Montefiore Medical Center and a 1-star overall rating.
Montefiore New Rochelle Hospital in New Rochelle, NY has 141 beds (fiscal year 2025 cost report); 242 beds are certified for Medicare. It discharged 5,912 inpatients that year, with 52.9% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), Montefiore New Rochelle Hospital reported net patient revenue of $176.4M and operating expenses of $256.8M, a margin on patient care of -45.6%. After other income and expenses its net income was -$51.9M (-25.4% of revenue), so it lost money that year.
Montefiore New Rochelle Hospital is part of Montefiore Medical Center, a health system with 7 hospitals based in Tarrytown, NY. It is a nonprofit hospital.
Montefiore New Rochelle Hospital has an overall rating of 1 out of 5 stars in the official hospital quality ratings. Patients rate it 2 out of 5 stars in the patient survey. 0 death rate measures are better and 1 worse than the national rate.
Yes, Montefiore New Rochelle Hospital provides emergency services.
227 Medicare clinicians list Montefiore New Rochelle Hospital as a hospital they work at, most often in Internal Medicine, Emergency Medicine, Diagnostic Radiology.
In 2024, Montefiore New Rochelle Hospital had 881 Medicare inpatient stays in 28 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 191 stays; Medicare paid $19,425.84 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $1,049 in payments to Montefiore New Rochelle Hospital as a teaching hospital ($1,049 general and - for research) from 2 companies.